Migraine Surgery: A Plastic Surgery Solution for Refractory Migraine Headache

被引:48
作者
Kung, Theodore A. [1 ]
Guyuron, Bahman [1 ]
Cederna, Paul S. [1 ]
机构
[1] Univ Michigan Hlth Syst, Sect Plast & Reconstruct Surg, Taubman Ctr 2130, Dept Surg, Ann Arbor, MI 48109 USA
关键词
TOXIN TYPE-A; CORRUGATOR SUPERCILII MUSCLE; DOUBLE-BLIND; PROPHYLACTIC TREATMENT; SURGICAL-TREATMENT; OCCIPITAL NERVES; DRUG-TREATMENT; ORAL TRIPTANS; UNITED-STATES; BURDEN;
D O I
10.1097/PRS.0b013e3181f95a01
中图分类号
R61 [外科手术学];
学科分类号
摘要
Migraine headache can be a debilitating condition that confers a substantial burden to the affected individual and to society. Despite significant advancements in the medical management of this challenging disorder, clinical data have revealed a proportion of patients who do not adequately respond to pharmacologic intervention and remain symptomatic. Recent insights into the pathogenesis of migraine headache argue against a central vasogenic cause and substantiate a peripheral mechanism involving compressed craniofacial nerves that contribute to the generation of migraine headache. Botulinum toxin injection is a relatively new treatment approach with demonstrated efficacy and supports a peripheral mechanism. Patients who fail optimal medical management and experience amelioration of headache pain after injection at specific anatomical locations can be considered for subsequent surgery to decompress the entrapped peripheral nerves. Migraine surgery is an exciting prospect for appropriately selected patients suffering from migraine headache and will continue to be a burgeoning field that is replete with investigative opportunities. (Plast. Reconstr. Surg. 127: 181, 2011.)
引用
收藏
页码:181 / 189
页数:9
相关论文
共 86 条
[1]   PROPHYLACTIC TREATMENT OF CLASSICAL AND NON-CLASSICAL MIGRAINE WITH METOPROLOL - A COMPARISON WITH PLACEBO [J].
ANDERSSON, PG ;
DAHL, S ;
HANSEN, JH ;
HANSEN, PE ;
HEDMAN, C ;
KRISTENSEN, TN ;
OLIVARIUS, BD .
CEPHALALGIA, 1983, 3 (04) :207-212
[2]   Lessons from placebo effects in migraine treatment [J].
Antonaci F. ;
Chimento P. ;
Diener H.-C. ;
Sances G. ;
Bono G. .
The Journal of Headache and Pain, 2007, 8 (1) :63-66
[3]  
Aoki KR, 2003, HEADACHE, V43, pS9
[4]   Botulinum toxin type A for the treatment of migraine [J].
Aurora, Sheena .
EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (08) :1085-1095
[5]   Botulinum toxin type A prophylactic treatment of episodic migraine: A randomized, double-blind, placebo-controlled exploratory study [J].
Aurora, Sheena K. ;
Gawel, Marek ;
Brandes, Jan L. ;
Pokta, Suriani ;
VanDenburgh, Amanda M. .
HEADACHE, 2007, 47 (04) :486-499
[6]   Surgical treatment of patients with refractory migraine headaches and intranasal contact points [J].
Behin, F ;
Behin, B ;
Bigal, ME ;
Lipton, RB .
CEPHALALGIA, 2005, 25 (06) :439-443
[7]   Migraine and intranasal contact point headache: Is there any connection? [J].
Behin F. ;
Lipton R.B. ;
Bigal M. .
Current Pain and Headache Reports, 2006, 10 (4) :312-315
[8]   Single-site botulinum toxin type A injection for elimination of migraine trigger points [J].
Behmand, RA ;
Tucker, T ;
Guyuron, B .
HEADACHE, 2003, 43 (10) :1085-1089
[9]   Ergotamine and dihydroergotamine: A review [J].
Marcelo E. Bigal ;
Stewart J. Tepper .
Current Pain and Headache Reports, 2003, 7 (1) :55-62
[10]  
Bigal Marcelo E, 2004, Am J Ther, V11, P130, DOI 10.1097/00045391-200403000-00008